• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TCR 依赖性的成熟记忆表型 T 细胞在小鼠中的转化。

TCR-dependent transformation of mature memory phenotype T cells in mice.

机构信息

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

出版信息

J Clin Invest. 2011 Oct;121(10):3834-45. doi: 10.1172/JCI37210. Epub 2011 Sep 19.

DOI:10.1172/JCI37210
PMID:21926465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3195451/
Abstract

A fundamental goal in cancer research is the identification of the cell types and signaling pathways capable of initiating and sustaining tumor growth, as this has the potential to reveal therapeutic targets. Stem and progenitor cells have been implicated in the genesis of select lymphoid malignancies. However, the identity of the cells in which mature lymphoid neoplasms are initiated remains unclear. Here, we investigate the origin of peripheral T cell lymphomas using mice in which Snf5, a chromatin remodelling-complex subunit with tumor suppressor activity, could be conditionally inactivated in developing T cells. In this model of mature peripheral T cell lymphomas, the cell of origin was a mature CD44hiCD122loCD8⁺ T cell that resembled a subset of memory cells that has capacity for self-renewal and robust expansion, features shared with stem cells. Further analysis showed that Snf5 loss led to activation of a Myc-driven signaling network and stem cell transcriptional program. Finally, lymphomagenesis and lymphoma proliferation depended upon TCR signaling, establishing what we believe to be a new paradigm for lymphoid malignancy growth. These findings suggest that the self-renewal and robust proliferative capacities of memory T cells are associated with vulnerability to oncogenic transformation. Our findings further suggest that agents that impinge upon TCR signaling may represent an effective therapeutic modality for this class of lethal human cancers.

摘要

癌症研究的一个基本目标是确定能够启动和维持肿瘤生长的细胞类型和信号通路,因为这有可能揭示治疗靶点。干细胞和祖细胞已被牵涉到某些淋巴恶性肿瘤的发生。然而,成熟淋巴细胞肿瘤起源的细胞身份仍不清楚。在这里,我们使用 Snf5 条件性失活的发育中的 T 细胞的小鼠来研究外周 T 细胞淋巴瘤的起源,Snf5 是一种具有肿瘤抑制活性的染色质重塑复合物亚基。在这种成熟外周 T 细胞淋巴瘤模型中,起源细胞是一种成熟的 CD44hiCD122loCD8+T 细胞,类似于具有自我更新和强大扩增能力的记忆细胞亚群,这些特征与干细胞共享。进一步的分析表明,Snf5 的缺失导致了 Myc 驱动的信号网络和干细胞转录程序的激活。最后,淋巴瘤的发生和淋巴瘤的增殖依赖于 TCR 信号,这建立了我们认为是淋巴恶性肿瘤生长的新范例。这些发现表明,记忆 T 细胞的自我更新和强大增殖能力与致癌转化的易感性有关。我们的发现进一步表明,抑制 TCR 信号的药物可能代表治疗这类致命人类癌症的有效治疗方式。

相似文献

1
TCR-dependent transformation of mature memory phenotype T cells in mice.TCR 依赖性的成熟记忆表型 T 细胞在小鼠中的转化。
J Clin Invest. 2011 Oct;121(10):3834-45. doi: 10.1172/JCI37210. Epub 2011 Sep 19.
2
Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.癌前PTEN基因缺陷的胸腺细胞激活微小RNA miR-146a和miR-146b,作为对抗恶性转化的细胞防御机制。
Blood. 2014 Jun 26;123(26):4089-100. doi: 10.1182/blood-2013-11-539411. Epub 2014 Apr 15.
3
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.慢性 T 细胞受体刺激通过表观遗传重编程揭示外周 T 细胞淋巴瘤中 NK 受体信号通路。
J Clin Invest. 2021 Jul 1;131(13). doi: 10.1172/JCI139675.
4
'Normal counterparts' of nodal peripheral T-cell lymphoma.淋巴结外周T细胞淋巴瘤的“正常对应物”
Hematol Oncol. 2006 Dec;24(4):175-80. doi: 10.1002/hon.786.
5
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.Mcl-1 升高会扰乱淋巴造血,促进造血干/祖细胞的转化,并增强药物耐药性。
Blood. 2010 Oct 28;116(17):3197-207. doi: 10.1182/blood-2010-04-281071. Epub 2010 Jul 14.
6
p57 regulates T-cell development and prevents lymphomagenesis by balancing p53 activity and pre-TCR signaling.p57 通过平衡 p53 活性和 pre-TCR 信号来调节 T 细胞发育并预防淋巴瘤的发生。
Blood. 2014 May 29;123(22):3429-39. doi: 10.1182/blood-2013-10-532390. Epub 2014 Mar 20.
7
A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.在缺乏正常TCR/MHC信号传导的情况下,Stat5b转基因能够诱导CD8 +淋巴细胞性淋巴瘤。
Blood. 2008 Jan 1;111(1):344-50. doi: 10.1182/blood-2007-04-084707. Epub 2007 Sep 21.
8
T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell.经重编程的 T 细胞衍生的小鼠 T 细胞受体驱动的淋巴瘤发生。
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18939-43. doi: 10.1073/pnas.1013230107. Epub 2010 Oct 18.
9
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.肿瘤抑制因子Snf5的失活会刺激细胞周期进程,并在致癌转化过程中与p53缺失协同作用。
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17745-50. doi: 10.1073/pnas.0509014102. Epub 2005 Nov 21.
10
MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.MYC 驱动的成熟鼠 B 细胞恶性转化需要同时抑制内在凋亡和 p53 活性。
Eur J Immunol. 2019 Mar;49(3):375-385. doi: 10.1002/eji.201847585. Epub 2018 Oct 12.

引用本文的文献

1
Unveiling cellular communications through rapid pan-membrane-protein labeling.通过快速全膜蛋白标记揭示细胞通讯
Nat Commun. 2025 Apr 15;16(1):3584. doi: 10.1038/s41467-025-58779-2.
2
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.儿童非肾母细胞瘤性肾癌生物学的标志性发现。
Nat Rev Urol. 2025 Jan 29. doi: 10.1038/s41585-024-00993-6.
3
SMARCB1-deficient malignant melanocytic uveal tumours: a new neural crest-derived tumour entity with SMARCB1-related germline predisposition.SMARCB1缺陷型恶性黑色素性葡萄膜肿瘤:一种新的源自神经嵴且具有SMARCB1相关种系易感性的肿瘤实体。
J Pathol. 2025 Mar;265(3):357-371. doi: 10.1002/path.6390. Epub 2025 Jan 23.
4
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.SMARCB1 表达缺失是人类和鼠外周 T 细胞淋巴瘤的一个亚型的特征。
Nat Commun. 2024 Oct 3;15(1):8571. doi: 10.1038/s41467-024-52826-0.
5
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression.PHF6 与 SWI/SNF 复合物合作,促进转录延伸。
Nat Commun. 2024 Aug 24;15(1):7303. doi: 10.1038/s41467-024-51566-5.
6
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity.表观遗传调节剂为理解疾病和提供治疗机会开辟了道路。
Genes Dev. 2024 Jul 19;38(11-12):473-503. doi: 10.1101/gad.351444.123.
7
CD47 promotes peripheral T cell survival by preventing dendritic cell-mediated T cell necroptosis.CD47 通过防止树突状细胞介导的 T 细胞坏死性凋亡促进外周 T 细胞存活。
Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2304943120. doi: 10.1073/pnas.2304943120. Epub 2023 Aug 7.
8
Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas.通过 CSF1R/JAK 抑制靶向淋巴瘤相关巨噬细胞扩增是外周 T 细胞淋巴瘤的治疗弱点。
Cancer Res Commun. 2022 Dec 30;2(12):1727-1737. doi: 10.1158/2767-9764.CRC-22-0336. eCollection 2022 Dec.
9
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms.GATA-3 是 T 细胞淋巴增生性肿瘤中的原癌基因。
Blood Cancer J. 2022 Nov 4;12(11):149. doi: 10.1038/s41408-022-00745-y.
10
Notch Signaling Promotes Mature T-Cell Lymphomagenesis.Notch 信号促进成熟 T 细胞淋巴瘤的发生。
Cancer Res. 2022 Oct 17;82(20):3763-3773. doi: 10.1158/0008-5472.CAN-22-1215.

本文引用的文献

1
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.外显子组测序鉴定出肾癌中 SWI/SNF 复合物基因 PBRM1 的高频突变。
Nature. 2011 Jan 27;469(7331):539-42. doi: 10.1038/nature09639. Epub 2011 Jan 19.
2
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.肿瘤抑制因子 Snf5 的缺失会导致 Hedgehog-Gli 信号通路的异常激活。
Nat Med. 2010 Dec;16(12):1429-33. doi: 10.1038/nm.2251. Epub 2010 Nov 14.
3
Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.抑癌基因与癌基因的表达调控
Cancer Cell. 2010 Oct 19;18(4):316-28. doi: 10.1016/j.ccr.2010.09.006.
4
A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.Myc 网络解释了胚胎干细胞和癌细胞转录程序之间的相似性。
Cell. 2010 Oct 15;143(2):313-24. doi: 10.1016/j.cell.2010.09.010.
5
ARID1A mutations in endometriosis-associated ovarian carcinomas.ARID1A 突变与子宫内膜异位症相关的卵巢癌。
N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8.
6
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.卵巢透明细胞癌中染色质重塑基因 ARID1A 的频繁突变。
Science. 2010 Oct 8;330(6001):228-31. doi: 10.1126/science.1196333. Epub 2010 Sep 8.
7
Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming.BAF 复合物的染色质重塑组件有助于重编程。
Cell. 2010 Jun 11;141(6):943-55. doi: 10.1016/j.cell.2010.04.037.
8
The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.融合激酶 ITK-SYK 模拟 T 细胞受体信号,并在周围 T 细胞淋巴瘤的条件性小鼠模型中驱动肿瘤发生。
J Exp Med. 2010 May 10;207(5):1031-44. doi: 10.1084/jem.20092042. Epub 2010 May 3.
9
Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.由SNF5肿瘤抑制因子缺失引起的肿瘤发生依赖于BRG1的活性,BRG1是SWI/SNF染色质重塑复合物的ATP酶。
Cancer Res. 2009 Oct 15;69(20):8094-101. doi: 10.1158/0008-5472.CAN-09-0733. Epub 2009 Sep 29.
10
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.TCL1A-TCRAD并置的T细胞幼淋巴细胞白血病中SMARCB1肿瘤抑制基因反复缺失但无突变。
Cancer Genet Cytogenet. 2009 Jul;192(1):44-7. doi: 10.1016/j.cancergencyto.2009.03.001.